Potassium Magnesium Aspartate Tablets
Function and Efficacy
Pharmacology Aspartic acid (Asp), also known as aspartic acid, contains two carboxyl groups and one amino group in the molecule. It is an acidic amino acid and is widely present in all proteins. Aspartic acid is a precursor of oxaloacetate and plays an important role in the tricarboxylic acid cycle, ornithine cycle and nucleotide synthesis. It has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability of cells such as nervous tissue, myocardium, and smooth muscle and the stability of the internal environment. It transports electrolytes to the myocardium, promotes muscle cell depolarization, maintains myocardial contractility, and reduces myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders. Aspartic acid participates in the ornithine cycle and promotes urea production
Ingredients
Each tablet of this product contains 158 mg of potassium aspartate (C4H6NO4K) and 140 mg of magnesium aspartate [(C4H6NO4)2Mg].
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Potassium L-aspartateIngredients |
Aspartic acid has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability and stability of the internal environment of cells such as nerve tissue, myocardium, and smooth muscle. It transports electrolytes to the myocardium, promotes myocyte depolarization, maintains myocardial contractility, and reduces myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders. Aspartic acid participates in the ornithine cycle and promotes urea production. More |
14007-45-5 | 11 | |
| Magnesium L-aspartateIngredients |
Aspartic acid has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability and stability of the internal environment of cells such as nerve tissue, myocardium, and smooth muscle. It transports electrolytes to the myocardium, promotes myocyte depolarization, maintains myocardial contractility, and reduces myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders. Aspartic acid participates in the ornithine cycle and promotes urea production. More |
2068-80-6 | 7 |
Appearance
This product is a white tablet.
Indication
Electrolyte supplement. Suitable for hypokalemia, improving symptoms of poisoning such as arrhythmia, nausea, vomiting caused by digitalis poisoning, for various heart diseases such as sequelae of myocarditis and chronic heart failure, and can also be used as an auxiliary treatment for acute and chronic hepatitis, cirrhosis, insufficient bile secretion and hepatic encephalopathy. 1 Cardiovascular system diseases (1) Arrhythmia and tachycardia caused by various reasons in adults and children, as well as arrhythmia caused by digitalis poisoning; (2) Myocardial infarction, coronary heart disease, angina pectoris, hypertension, etc.; (3) Myocardial damage caused by tumor chemotherapy. 2 Digestive system diseases Acute and chronic hepatitis, jaundice,
Usage and Dosage
Oral administration, 1 tablet at a time, 3 times a day.
Adverse Reactions
Nausea may occur occasionally, but will resolve after medication is discontinued.
Precautions
It is contraindicated in patients with hyperkalemia, hypermagnesemia, severe renal dysfunction and severe atrioventricular block.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: The dosage of this product remains unchanged for elderly patients.
Drug Interactions
It should not be used in combination with potassium-sparing diuretics.
Storage
Store in a sealed container away from light.
Packaging Specification
Each tablet contains 0.158 g of anhydrous potassium aspartate (equivalent to 36.1 mg of potassium ions) and 0.140 g of anhydrous magnesium aspartate (equivalent to 11.8 mg of magnesium ions).
Validity Period
24 months
Manufacturer
Beijing Jialin Pharmaceutical Co., Ltd.
-
Founded in:
1977-08-05 -
Address:
No. 2 Jiuxianqiao Road, Dashanzi, Dongzhimenwai, Chaoyang District, Beijing -
Tax NO.:
911101051016610948 -
Registered Funds:
30.5 million yuan -
Website:
-
Email: